Turkish Archives of Pediatrics
Review

An Update on Patent Ductus Arteriosus and What is Coming Next

1.

Division of Neonatology, Department of Pediatrics, Ankara University, Faculty of Medicine, Ankara, Turkey

2.

Division of Neonatology, Loma Linda University School of Medicine, California, USA

3.

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

4.

Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden

5.

Division of Neonatology, Buca Seyfi Demirsoy Training and Research Hospital, İzmir, Turkey

6.

Division of Neonatology, Department of Pediatrics, İzmir Katip Çelebi University, Faculty of Medicine, İzmir, Turkey

7.

Department of Maternal and Child Health, University of Roma La Sapienza, Rome, Italy

8.

Division of Neonatology, Department of Pediatrics University of Health Science, Şişli Hamidiye Etfal Education and Research Hospital, , İstanbul, Turkey

9.

Department of Congenital Heart Disease/Pediatric Cardiology, Charité–Universitätsmedizin Berlin and Deutsches Herzzentrum Berlin (DHZB), Berlin, Germany

10.

Division of Neonatology, Department of Pediatrics, İstanbul Medeniyet University, İstanbul, Turkey

11.

Department of Pediatrics and Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA

Turk Arch Pediatr 2022; 57: 118-131
DOI: 10.5152/TurkArchPediatr.2022.21361
Read: 1318 Downloads: 491 Published: 01 March 2022

Patent ductus arteriosus is the most common cardiovascular condition in preterm infants. There is a significant uncertainty about when and how to close ductus arteriosus in preterm infants due to a high spontaneous closure rate even in very immature preterm infants. Diagnosis and management of patent ductus arteriosus remain a challenge for both neonatologists and pediatric cardiologists. Researchers have tried to define a balance between an expectant approach and active treatment in selected infants. This review aimed to focus on the pathophysiology and management of patent ductus arteriosus and to make suggestions about approaches that might eliminate the association of morbidities with patent ductus arteriosus.

Cite this article as: Erdeve Ö, Okulu E, Singh Y, et al. An update on patent ductus arteriosus and what is next?. Turk Arch Pediatr. 2022;57(2):118-131.

Files
EISSN 2757-6256